Skip to main content
. 2019 Mar 19;2(1):69–81. doi: 10.20517/cdr.2018.20

Figure 3.

Figure 3

The effect of bevacizumab on VEGF signalling pathway. This figure shows, that bevacizumab is primarily directed to bind VEGF signalling molecules. Such interaction leads to inactivity of VEGF binding to its receptors and as a result it reduces neoangiogenesis. VEGF: vascular endothelial growth factor